Kate Sahan

Kate's current research interests include:

• the ethics of innovative trial designs including decentralised or remote trials, adaptive platform trials and learning health care.
• PPIE in research and questions of inclusion
• research ethics governance with special interests in the governance of emergency research and policy-related research
• population health ethics, e.g. the ethics of genomic medicine in cancer care, and the ethics of behavioural science for public health.

As a former postdoctoral researcher at Erasmus Universiteit, Rotterdam, Kate was involved in two EU Horizon 2020 projects exploring global opportunities and challenges of implementing about responsible research and innovation policy. Kate has also conducted postdoctoral qualitative research with Professor Phaik Yeong Cheah at MORU in Bangkok on community engagement and the social context of mass drug administration for malaria.

Kate is a member of the SSH IDREC, one of three RECs at the University of Oxford; she is part of the Athena Swan Self Assessment Team for Oxford Population Health for 2024-29, co-leading the Career Progression Working Group; she is co-chair of the UK Care Quality Commission Ethics Review Panel.

Kate co-leads and teaches on the ethics and health economics module of the MSc in Precision Cancer Medicine at the Department of Oncology, and teaches on the MSc in Clinical Trials at Oxford Population Health.

Kate holds a DPhil in Population Health and an MA Oxon in Literae Humaniores from the University of Oxford. Kate previously worked as a clinical research coordinator, as part of the 2014 Oxford REF project management team, and as manager of the Oxford SSH IDREC. She has also served as a lay member of the Oxford C NHS Research Ethics Committee.